Response by du Fay de Lavallaz et al to Letter Regarding Article, “B-Type Natriuretic Peptides and Cardiac Troponins for Diagnosis and Risk-Stratification of Syncope”-Reference-Cited by-同舟云学术

Response by du Fay de Lavallaz et al to Letter Regarding Article, “B-Type Natriuretic Peptides and Cardiac Troponins for Diagnosis and Risk-Stratification of Syncope”

Published:2019-10-22 Issue:17 Volume:140 Page:
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

du Fay de Lavallaz Jeanne¹²,Badertscher Patrick¹³,Müller Christian¹⁴

Affiliation:

1. Cardiovascular Research Institute Basel, Switzerland (J.d.F.d.L., P.B., C.M.).

2. Rush University Hospital, Chicago, IL (J.d.F.d.L).

3. Charleston Hospital, SC (P.B.).

4. University Hospital Basel, Switzerland (C.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. B-Type Natriuretic Peptides and Cardiac Troponins for Diagnosis and Risk-Stratification of Syncope

2. Prohormones in the Early Diagnosis of Cardiac Syncope

3. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

4. Bradycardia and B-type natriuretic peptide

5. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk stratification tools for patients with syncope in emergency medical services and emergency departments: a scoping review;Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine;2023-09-18

2. Evaluation of the cardiovascular risk in patients undergoing major non-cardiac surgery: role of cardiac-specific biomarkers;Clinical Chemistry and Laboratory Medicine (CCLM);2022-07-20

3. Gender-Related Differences in Heart Failure Biomarkers;Frontiers in Cardiovascular Medicine;2021-01-05

4. Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool (Preprint);2020-10-22

5. Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers;Clinical Chemistry and Laboratory Medicine (CCLM);2020-07-21